Concurrent chemoradiation for NSCLC: improving outcomes with modern techniques

被引：0
|
作者：
Kuciejewska, A. [1 ]
Smith, D. [1 ]
Ahmad, S. [1 ]
机构：
[1] Guys Canc Ctr, Dept Clin Oncol, London, England
来源：
LUNG CANCER | 2017年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
123
引用
收藏
页码：S56 / S56
页数：1
相关论文
共 50 条
  • [41] Improving cardiovascular monitoring through modern techniques
    Karrakchou, M
    VibeRheymer, K
    Vesin, JM
    Pruvot, E
    Kunt, M
    IEEE ENGINEERING IN MEDICINE AND BIOLOGY MAGAZINE, 1996, 15 (05): : 68 - 78
  • [42] Improving Crossmatch Techniques and Graft Outcomes
    Vincent, L.
    INDIAN JOURNAL OF NEPHROLOGY, 2018, 28 (06) : 491 - +
  • [43] Concurrent chemoradiation: myth or reality
    Manuel de las Heras González
    Revista de Oncología, 2002, 4 (7): : 402 - 409
  • [44] Concurrent Chemoradiation for Vaginal Cancer
    Miyamoto, David T.
    Viswanathan, Akila N.
    PLOS ONE, 2013, 8 (06):
  • [45] Concurrent chemoradiation in lung cancer
    Girard, N
    Mornex, F
    BULLETIN DU CANCER, 2005, 92 (12) : 1048 - 1064
  • [46] Real-World Data Comparing Cisplatin/Vinorelbine and Carboplatin/Paclitaxel in Concurrent Chemoradiation for Non-Small Cell Lung Cancer (NSCLC): Safety and Outcomes
    Chan, Christopher Wei En
    Abdelaziz, Noha
    Makady, Nafie Faisal
    LUNG CANCER, 2025, 200
  • [47] Real-World Outcomes of Stage III NSCLC Treated with Chemoradiation plus /- durvalumab
    Duan, R.
    Kordon, A.
    Kwan, M.
    Yadav, P.
    Thomas, T. O.
    Abazeed, M.
    Gharzai, L. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (01): : E11 - E11
  • [48] Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial
    Liu, Yufei
    Yao, Luyang
    Kalhor, Neda
    Carter, Brett W.
    Altan, Mehmet
    Blumenschein, George
    Byers, Lauren A.
    Fossella, Frank
    Gibbons, Don L.
    Kurie, Jonathan M.
    Lu, Charles
    Skoulidis, Ferdinandos
    Chang, Joe Y.
    Liao, Zhongxing
    Gomez, Daniel R.
    O'Reilly, Michael
    Heymach, John, V
    Tsao, Anne S.
    Lin, Steven H.
    LUNG CANCER, 2022, 174 : 112 - 117
  • [49] PFS and Cardiac-Toxicity-Adjusted-PFS As Predictors of OS in Locally Advanced NSCLC Treated with Concurrent Chemoradiation
    Hu, C.
    Machtay, M.
    Dignam, J.
    Paulus, R.
    Bradley, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S373 - S373
  • [50] No Improvement of progression free Survival of Patients with locally advanced NSCLC through consolidation Chemotherapy after concurrent Chemoradiation
    Ebert, Nadja
    Baumann, Michael
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (02) : 133 - 135
12345